[Federal Register Volume 68, Number 103 (Thursday, May 29, 2003)]
[Notices]
[Page 32044]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-13325]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Public Meeting of the President's Council on Bioethics on June 
12-13, 2003

AGENCY: The President's Council on Bioethics, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The President's Council on Bioethics will hold its eleventh 
meeting, at which it will discuss, among other things, current research 
into overcoming immune rejection in embryonic and adult stem-cell 
therapies (Silviu Itescu, M.D., Columbia University College of 
Physicians and Surgeons). The Council will hear testimony from various 
interested parties on current and possible future regulation of 
biotechnologies that touch the beginnings of human life. Panel 1: 
Robert Brzyski, M.D., Society for Assisted Reproductive Technology; 
John Bruchalski, M.D., Tepeyac Family Center, Wash., DC (invited); 
Kathy Hudson, Ph.D., Genetics and Public Policy Center; Pamela Madsen, 
American Infertility Association; Mary Mahowald, Ph.D. (University of 
Chicago); and David Smith, Ph.D., Indiana University. Panel 2: Richard 
Doerflinger, U.S. Catholic Bishops Conference; Andrew Kimbrell, 
International Center for Technology Assessment; William Kristol, 
Bioethics Project; Michael Manganiello, Coalition for the Advancement 
of Medical Research; Maxine Singer, Ph.D., Chair, Committees on 
Science, Engineering, & Public Policy, National Academies; Michael 
Werner, Biotechnology Industry Organization. Subjects discussed at past 
Council meetings (and potentially touched on at this meeting) include: 
human cloning; embryonic stem cell research; the patentability of human 
genes, tissues, and organisms; assisted reproduction; preimplantation 
genetic diagnosis (PGD) and screening; sex selection techniques; 
inheritable genetic modification (IGM); international models of biotech 
regulation; organ procurement for transplantation; extra-therapeutic 
powers to enhance or improve human mood, memory, and muscles; and 
research to extend the human lifespan.

DATES: The meeting will take place Thursday, June 12, 2003, from 9:00 
am to 5:15 pm ET; and Friday, June 13, 2003, from 8:30 am to 12:30 pm 
ET.

ADDRESSES: Wyndham Washington DC, 1400 M Street, NW., Washington, DC 
20005.
    Public Comments: The meeting agenda will be posted at http://www.bioethics.gov. Members of the public may comment, either in person 
or in writing. A period of time will be set aside during the meeting to 
receive comments from the public, beginning at 11:30 am, on Friday, 
June 13. Comments will be limited to no more than five minutes per 
speaker or organization. Please inform Ms. Diane Gianelli, Director of 
Communications, in advance of your intention to make a public 
statement, giving her your name, affiliation, and a brief description 
of the topic or nature of your comments. To submit a written statement, 
mail or e-mail it to Ms. Gianelli at one of the addresses given below.

FOR FURTHER INFORMATION CONTACT: Ms. Diane Gianelli, Director of 
Communications, The President's Council on Bioethics, Suite 600, 1801 
Pennsylvania Avenue, Washington, DC 20006. Telephone: 202/296-4669. E-
mail: [email protected]. Web site: http://www.bioethics.gov.

    Dated: May 21, 2003.
Dean Clancy,
Executive Director, The President's Council on Bioethics.
[FR Doc. 03-13325 Filed 5-28-03; 8:45 am]
BILLING CODE 4110-60-U